PURINE NUCLEOSIDE PHOSPHORYLASE - A TARGET FOR DRUG DESIGN
PURINE NUCLEOSIDE PHOSPHORYLASE - A TARGET FOR DRUG DESIGN
复制标题
DOI:
10.1002/med.2610130302
复制
发表时间:
1993-05-01
影响因子:
13.3
通讯作者:
MONTGOMERY, JA
中科院分区:
文献类型:
--
作者:
MONTGOMERY, JA
Mammalian purine nucleoside phosphorylase (PNP, purine nucleoside orthophosphate ribosyltransferase, EC 2.4. 2.1) catalyzes the reversible phosphorolysis of the ribonucleosides and 2'-deoxyribonucleosides of guanine, hypoxanthine, and a number of related nucleoside congeners (Fig. 1). l Adenine is also a substrate of the mammalian enzyme, but the kinetic parameters are so unfavorable that it is highly unlikely that this reaction or the phosphorolysis of adenosine have a role in normal cellular metabolism. 2 Instead, PNP rapidly degrades the products of adenosine deaminase (ADA), inosine, and 2'-deoxyinosine. The activity of PNP exceeds that of ADA in all human fetal tissues examined except thy mu^.^ Although under equilibrium conditions the isolated enzyme catalyses nucleoside synthesis, it normally acts in the phosphorolytic direction in intact cells. PNP functions as a catabolic enzyme when it is coupled with xanthine oxidase in some tissues, and as a salvage enzyme when it is coupled with hypoxanthine-guanine phosphoribosyltransferase (HGPRT). Since both ribo-and 2'-deoxyribonucleosides are salvaged by PNP to form only ribonucleotides, it may, in conjunction with ADA, limit the production of 2'-deoxyribonucleotides to their synthesis by ribonucleoside diphosphate reductase, a highly regulated enzyme.PNP has been isolated from both eukaryotic and prokaryotic cells, but while the mammalian enzyme is specific for the 6-oxypurines and analogs thereof, PNPs from other organisms vary in their specificity. This review will deal primarily with inhibitors of the enzyme from mammalian sources.